Savant Capital Management »

Amylyx Pharmaceuticals shares owned by Savant Capital Management

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Savant Capital Management from 13F filings

Historical chart of Savant Capital Management investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Savant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Savant Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $187k 58k 3.24
2024-06-30 $182k 96k 1.90

More positions owned by Savant Capital Management

American Centy Etf Tr Avantis Emgmkt (AVEM)
Dimensional Etf Trust Us Mktwide Value (DFUV)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Vanguard Index Fds Total Stk Mkt (VTI)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Dimensional Etf Trust Internatnal Val (DFIV)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Dimensional Etf Trust Intl High Profit (DIHP)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Savant Capital Management

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
BlackRock
Goldman Sachs Group
BlackRock
Citadel Advisors
Perceptive Advisors
Alyeska Investment Group
683 Capital Management
Almitas Capital
Standard Life Aberdeen
Acadian Asset Management
Nantahala Capital Management
Two Sigma Investments
Two Sigma Advisers
Farallon Capital Management

View all funds holding Amylyx Pharmaceuticals